The AJMC® Chronic Kidney Disease compendium is a comprehensive resource for clinical news and expert insights on the condition and treatment of loss of kidney function.
March 28th 2024
The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Milken Institute's Sarah Wells Kocsis Talks About CKD Care Moving Forward
September 8th 2022Sarah Wells Kocsis, MBA, coauthor of the Milken Institute report, “Chronic Kidney Disease: Finding a Path to Prevention, Earlier Detection, and Management,” discusses how the health care system can better suit the needs of patients with chronic kidney disease (CKD).
Watch
Milken Institute's Sarah Wells Kocsis Outlines How to Improve Earlier Detection of CKD
August 30th 2022Sarah Wells Kocsis, MBA, is co-author of the Milken Institute report, “Chronic Kidney Disease: Finding a Path to Prevention, Earlier Detection, and Management.” She spoke to The American Journal of Managed Care® about the findings of the report and how they can be incorporated into care for patients with chronic kidney disease (CKD).
Watch
Milken Institute's Sarah Wells Kocsis on How Climate Change, Aging Impact CKD Care
August 24th 2022Sarah Wells Kocsis, MBA, is co-author of the Milken Institute report, “Chronic Kidney Disease: Finding a Path to Prevention, Earlier Detection, and Management.” She spoke to The American Journal of Managed Care® about the findings of the report and how they can be incorporated into care for patients with chronic kidney disease (CKD).
Watch
SGLT2 Inhibitors, Combination Therapy Needed to Stem the Tide of CKD in Diabetes
August 20th 2022Katherine R. Tuttle, MD, FASN, FACP, FNKF, a nephrologist from the University of Washington and Providence Health Care, discussed new consensus guidelines that call for the early use of sodium glucose cotransporter 2 (SGLT2) inhibitors, GLP-1 receptor agonists, and finerenone in the care of patients with both chronic kidney disease (CKD) and diabetes.
Read More
Milken Institute's Sarah Wells Kocsis Highlights Key Findings of Her Research on CKD
August 14th 2022Sarah Wells Kocsis, MBA, is co-author of the Milken Institute report, “Chronic Kidney Disease: Finding a Path to Prevention, Earlier Detection, and Management.” She spoke to The American Journal of Managed Care® about the findings of the report and how they can be incorporated into care for patients with chronic kidney disease (CKD).
Watch
As Health Disparities “Weave Their Way Through Hypertension,” New Agents Are on the Way
August 8th 2022Coverage from the 2022 Congress of the American Society for Preventive Cardiology (ASPC) in Louisville, Kentucky, featuring 3 experts on aspects of hypertension treatment: Keith C. Ferdinand, MD, of Tulane University School of Medicine; Kim Allan Williams, MD, of the University of Louisville; and George C. Bakris, MD, of the University of Chicago Medicine.
Read More
Model Suggests Giving Kidneys to Patients on Dialysis a Better Use of Resources
August 1st 2022A recent modeling study found that allocating kidneys to patients receiving dialysis was a better use of the organs from a societal perspective compared with giving kidneys to those on a preemptive waiting list.
Read More
Difference in eGFR Values Based on Cystatin C vs Creatinine Could Indicate Higher HF Risk
July 18th 2022A prospective cohort study found that in patients with chronic kidney disease, large differences in their glomerular filtration rate (eGFR) based on cystatin C vs creatinine were associated with risk of incident heart failure (HF).
Read More
What We’re Reading: FDA to Cut Nicotine Levels; Insulin Pricing Bill; DaVita Loses Dialysis Case
June 22nd 2022The FDA plans to set a maximum nicotine level in cigarettes and tobacco products to reduce addictiveness; a bipartisan bill would place a $35 monthly cap on insulin for patients with private insurance or Medicare; the Supreme Court ruled that an Ohio hospital’s employee health plan did not violate federal law by limiting coverage for outpatient dialysis.
Read More
Study Finds Machine Learning Effective in Evaluating CKD Prognosis
June 7th 2022A retrospective study found that 3 machine learning models demonstrated equivalent predictability and greater sensitivity in the prognosis of chronic kidney disease (CKD) compared with the Kidney Failure Risk Equation.
Read More
Study Finds Albuminuria Associated With Cognitive Decline, Increased Risk of Dementia
May 25th 2022A longitudinal cohort study found that mild albuminuria was associated with cognitive decline, worse baseline cognitive function, and increased risk of incident cognitive impairment and dementia.
Read More
GFR, ABI, High Blood Pressure Associated With Poor Prognosis in Patients With CKD
May 23rd 2022A recent study found that patients with chronic kidney disease (CKD) had a poor prognosis based on glomerular filtration rate (GFR), ankle-brachial index (ABI), and high systolic blood pressure in a 16-week exercise program.
Read More
Glucose-Lowering Treatment Patterns in Patients With Diabetic Kidney Disease
Real-world treatment of diabetic kidney disease in the United States, based on national-level health care claims and electronic health records data, is inconsistent with the current guidelines.
Read More